Journal Article
Meta-Analysis
Review
Add like
Add dislike
Add to saved papers

A Meta-Analysis of Transfemoral Endovascular Treatment of Common Carotid Artery Lesions.

OBJECTIVE: High-grade stenoses of the common carotid artery (CCA) are rare and represent a therapeutic dilemma for the treating physician. Endovascular treatment through antegrade access has been proposed as a less invasive treatment option. The aim of this study was to review the existing literature on such a procedure.

METHODS: A meta-analysis of all studies reporting on endovascular treatment for the treatment of CCA was performed.

RESULTS: Six studies, including 227 patients, were identified. Forty-nine percent of the patients were male, and 55% symptomatic. Lesions were located in CCA in 237 cases, in innominate artery in 4 cases, combined with internal carotid artery in 28 and subclavian artery in 5 cases. The reported technical success of the procedure was 97.9%. In the 234 successful endovascular treatments, a stent was implanted. Thirty-day mortality and stroke rate were 0.4% and 3.1%, respectively. During a mean follow-up of 8.4 to 31.7 months, 4 patients presented symptoms of cerebral ischemia and 18 died (none related to the procedure). Thirty-one patients developed restenosis of the CCA lesion; successful repercutaneous transluminal angioplasty was performed in 9 cases.

CONCLUSIONS: This meta-analysis reported the largest collection of patients having undergone endovascular treatment of CCA stenosis or occlusion. Results from this study showed that 30-day mortality and stroke rate were 0.4% and 3.1%, respectively. The procedure is absolutely effective, and no significant change of stroke was found with or without an embolic protection device. In sum, balloon angioplasty with stenting of the component of this disease should be pursued to decrease the risk of stroke.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app